Otsuka Holdings Company Description
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.
It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts.
In addition, the company offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams.
Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table.
The company was founded in 1921 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 1921 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 35,338 |
| CEO | Makoto Inoue |
Contact Details
Address: 2-9 Kanda-Tsukasamachi Tokyo, 101-0048 Japan | |
| Phone | 81 3 6717 1410 |
| Website | otsuka.com |
Stock Details
| Ticker Symbol | OTSKY |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | US6891641010 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Makoto Inoue | President, Chief Executive Officer and Representative Director |
| Yuko Makino | Chief Financial Officer and Executive Director |
| Noriko Tojo | Executive Director |
| Yoshiro Matsuo | Executive Deputy President and Representative Director |
| Masayuki Kobayashi | Executive Director |
| Shuichi Takagi | Executive Director |
| Tomohiro Emura Ph.D. | Executive Vice President and Operating Officer of IR, Public Relations, and Sustainability Promotion |
| Chiaki Sakurai | Senior EVice President, Operating Officer and Dir. of Nutraceutical Business, Global Strat. and Planning Headquarters |
| Manabu Kawata | Executive Vice President and Operating Officer of Business Development Department |
| Keiso Yamasaki | Executive Vice President, Operating Officer and Director of Corporate Planning Dept., Business Insights and Analytics |